Biotech Leader Pendulum Therapeutics Appoints Madison Reed CEO Amy Errett
Pendulum Therapeutics, has appointed Amy Errett—founder and CEO of direct-to-consumer beauty brand Madison Reed—to its board of directors, signaling the company’s strategic focus on scaling its clinically validated microbiome products for broader consumer markets. Errett, a four-time entrepreneur and former Maveron venture partner, brings deep expertise in building beloved, mission-driven consumer brands and omnichannel business models, which Pendulum CEO Colleen Cutcliffe, PhD, says will be invaluable as the company expands access to groundbreaking microbiome innovation
Read more here
Source: Los Angeles Times
Posted on: July 14, 2026